Oscar Health, Inc. (OSCR) stock
OSCRNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3028% above fair value
$31.33+0.28 (+0.90%)
Close on Nov 16, 2026Market cap $9.67BP/E 22.4Yield –
Oscar Health ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Oscar Health's ebitda for the twelve months ending Jun 30, 2026 was $657.96M. For fiscal 2025 it was -$367.47M, down 511.0% from the year before. The highest annual figure on record is $89.41M in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$367.47M | -511.0% |
| FY2024 | Dec 31, 2024 | $89.41M | – |
| FY2023 | Dec 31, 2023 | -$204.92M | – |
| FY2022 | Dec 31, 2022 | -$574.58M | – |
| FY2021 | Dec 31, 2021 | -$529.88M | – |
| FY2020 | Dec 31, 2020 | -$390.98M | – |
| FY2019 | Dec 31, 2019 | -$252.49M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $394.67M | – |
| Q1 FY2026 | Mar 31, 2026 | $711.10M | +134.0% |
| Q4 FY2025 | Dec 31, 2025 | -$325.87M | – |
| Q3 FY2025 | Sep 30, 2025 | -$121.94M | – |
| Q2 FY2025 | Jun 30, 2025 | -$223.51M | -396.4% |
| Q1 FY2025 | Mar 31, 2025 | $303.85M | +57.1% |
| Q4 FY2024 | Dec 31, 2024 | -$138.50M | – |
| Q3 FY2024 | Sep 30, 2024 | -$40.87M | – |
| Q2 FY2024 | Jun 30, 2024 | $75.41M | +3188.8% |
| Q1 FY2024 | Mar 31, 2024 | $193.37M | – |
| Q4 FY2023 | Dec 31, 2023 | -$137.74M | – |
| Q3 FY2023 | Sep 30, 2023 | -$49.05M | – |
| Q2 FY2023 | Jun 30, 2023 | $2.29M | – |
| Q1 FY2023 | Mar 31, 2023 | -$20.43M | – |
| Q4 FY2022 | Dec 31, 2022 | -$218.74M | – |
| Q3 FY2022 | Sep 30, 2022 | -$188.31M | – |
| Q2 FY2022 | Jun 30, 2022 | -$102.80M | – |
| Q1 FY2022 | Mar 31, 2022 | -$64.73M | – |
| Q4 FY2021 | Dec 31, 2021 | -$192.28M | – |
| Q3 FY2021 | Sep 30, 2021 | -$208.04M | – |
| Q2 FY2021 | Jun 30, 2021 | -$68.92M | – |
| Q1 FY2021 | Mar 31, 2021 | -$60.64M | – |
| Q4 FY2020 | Dec 31, 2020 | -$183.54M | – |
| Q3 FY2020 | Sep 30, 2020 | -$77.21M | – |
| Q2 FY2020 | Jun 30, 2020 | -$36.83M | – |
| Q1 FY2020 | Mar 31, 2020 | -$93.40M | – |
See a number that looks wrong?